OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea
· Delayed Price · Currency is KRW
47,650
-2,550 (-5.08%)
Apr 28, 2025, 3:30 PM KST
OliX Pharmaceuticals Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Apr '25 Apr 25, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 992,721 | 355,531 | 233,568 | 278,859 | 561,830 | 681,166 | |
| Market Cap Growth | 52.22% | 52.22% | -16.24% | -50.37% | -17.52% | 146.02% | |
| Enterprise Value | 1,020,123 | 392,701 | 247,386 | 238,494 | 524,125 | 657,538 | |
| Last Close Price | 50200.00 | 19260.00 | 14580.00 | 20350.00 | 41000.00 | 50300.00 | |
| PS Ratio | 174.86 | 62.63 | 13.69 | 29.92 | 152.91 | 275.30 | |
| PB Ratio | 53.74 | 19.25 | 4.64 | 4.21 | 28.95 | 15.02 | |
| P/TBV Ratio | 61.49 | 22.02 | 4.92 | 4.48 | 34.29 | 15.93 | |
| EV/Sales Ratio | 179.69 | 69.17 | 14.50 | 25.59 | 142.64 | 265.75 | |
| Debt / Equity Ratio | 2.12 | 2.12 | 0.78 | 0.67 | 1.92 | 0.32 | |
| Asset Turnover | 0.07 | 0.07 | 0.14 | 0.09 | 0.04 | 0.04 | |
| Inventory Turnover | 0.49 | 0.49 | 0.28 | 0.40 | 0.51 | 0.18 | |
| Quick Ratio | 0.44 | 0.44 | 4.71 | 1.59 | 1.24 | 15.21 | |
| Current Ratio | 0.52 | 0.52 | 4.90 | 1.65 | 1.29 | 15.38 | |
| Return on Equity (ROE) | -118.18% | -118.18% | -32.78% | -65.68% | -90.11% | -44.48% | |
| Return on Assets (ROA) | -22.20% | -22.20% | -9.65% | -12.75% | -18.33% | -16.40% | |
| Return on Capital (ROIC) | -26.23% | -26.23% | -11.37% | -16.76% | -25.98% | -19.92% | |
| Earnings Yield | -4.10% | -11.44% | -8.18% | -6.99% | -5.29% | -2.85% | |
| FCF Yield | -4.18% | -11.68% | -12.84% | -11.80% | -3.62% | -0.67% | |
| Buyback Yield / Dilution | -16.73% | -16.73% | -5.30% | -0.13% | -4.06% | -1.00% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.